Abstract
In the present brief survey on new developments in the drug treatment of essential hypertension the following issues are summarized: the treatment of hypertension in diabetics, patients with left ventricular hypertrophy, and the elderly; new antihypertensive drugs, including a hybrid (multifactorial) antihypertensive drug with both calcium and α1-adrenoceptor antagonistic activity, as well as angiotensin II-receptor antagonists; and finally, gene therapy in hypertension.
| Original language | English |
|---|---|
| Pages (from-to) | 568-572 |
| Journal | Current opinion in cardiology |
| Volume | 9 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1994 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'What can we expect in antihypertensive drug therapy?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver